Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Shida-Sakazume T et al. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor. 2015 PLoS ONE pmid:25803864
Lautenschläger I et al. Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis. 2015 PLoS ONE pmid:25793535
Bate C and Williams A α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2. 2015 Biomolecules pmid:25761116
Sahu RP Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells. 2015 Mol Med Rep pmid:25695262
Reznichenko A and Korstanje R The role of platelet-activating factor in mesangial pathophysiology. 2015 Am. J. Pathol. pmid:25655028
Jeewandara C et al. Platelet activating factor contributes to vascular leak in acute dengue infection. 2015 PLoS Negl Trop Dis pmid:25646838
Valli A et al. Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways. 2015 Oncotarget pmid:25605240
Sun L et al. PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer. 2015 Int J Clin Exp Pathol pmid:25755731
Wang Y et al. Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis. 2015 Int J Nanomedicine pmid:26604756
van Doorn R and de Gruijl F Chromatin Modifications and Mast Cell Migration in UV-Induced Immunosuppression, an Epigenetic Piece of The Puzzle. 2015 J. Invest. Dermatol. pmid:26569583
Pałgan K and Bartuzi Z Platelet activating factor in allergies. 2015 Int J Immunopathol Pharmacol pmid:26486136
Hergott CB et al. Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection. 2015 J. Clin. Invest. pmid:26426079
Jiao D et al. Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice. 2014 May-Jun Cell. Immunol. pmid:24751884
Yamauchi A et al. Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients. 2014 J. Immunol. Methods pmid:24370750
Flasiński M et al. Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level. 2014 J R Soc Interface pmid:24694892
Sato A et al. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo. 2014 Eur. J. Pharmacol. pmid:25455842
Zebrowska A et al. Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis. 2014 Mediators Inflamm. pmid:25400334
Sahu RP et al. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. 2014 Cancer Res. pmid:25304264
Yu Y et al. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells. 2014 J. Exp. Clin. Cancer Res. pmid:25261977
Agrawal V et al. Platelet-activating factor: a role in preterm delivery and an essential interaction with Toll-like receptor signaling in mice. 2014 Biol. Reprod. pmid:25253732
Wang M et al. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine. 2014 Life Sci. pmid:25252221
Liu X et al. Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. 2014 Thromb. Res. pmid:25223809
Kang LP et al. Steroidal saponins from Tribulus terrestris. 2014 Phytochemistry pmid:25172515
Wu KZ et al. Establishment of the method for screening the potential targets and effective components of huatuo reconstruction pill. 2014 Interdiscip Sci pmid:25172450
Nitoda E et al. Correlation of platelet activating factor and age-related macular degeneration. 2014 Expert Opin. Ther. Targets pmid:25077601
Sirangelo I et al. Platelet-activating factor mediates the cytotoxicity induced by W7FW14F apomyoglobin amyloid aggregates in neuroblastoma cells. 2014 J. Cell. Biochem. pmid:25053109
Xanthopoulou MN et al. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells. 2014 Food Chem pmid:25038648
Concha C et al. Oxidative response of neutrophils to platelet-activating factor is altered during acute ruminal acidosis induced by oligofructose in heifers. 2014 J. Vet. Sci. pmid:25013355
Mazereeuw G et al. Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. 2014 J Neuroinflammation pmid:24996486
Uhlig S et al. Differential regulation of lung endothelial permeability in vitro and in situ. 2014 Cell. Physiol. Biochem. pmid:24977477
Triggiani M et al. Anaphylaxis and cardiovascular diseases: a dangerous liaison. 2014 Curr Opin Allergy Clin Immunol pmid:24915548
Jin XL and O'Neill C Systematic analysis of the factors that adversely affect the rate of cell accumulation in mouse embryos during their culture in vitro. 2014 Reprod. Biol. Endocrinol. pmid:24885989
Wu H et al. Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice. 2014 PLoS ONE pmid:24671173
Papakonstantinou VD et al. In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients. 2014 Lipids Health Dis pmid:24884881
Marathe GK et al. To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase. 2014 J. Lipid Res. pmid:24859738
Zanatta AL et al. Fish oil supplementation decreases oxidative stress but does not affect platelet-activating factor bioactivity in lungs of asthmatic rats. 2014 Lipids pmid:24858941
Mitchell MJ et al. Fluid shear stress increases neutrophil activation via platelet-activating factor. 2014 Biophys. J. pmid:24853753
Carlioglu A et al. The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome. 2014 Arch. Gynecol. Obstet. pmid:24840107
Yu Y et al. Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells. 2014 J Ovarian Res pmid:24721622
Forkel S et al. Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models. 2014 J. Invest. Dermatol. pmid:24714204
Kim SJ et al. Quantitative determination of major platelet activating factors from human plasma. 2014 Anal Bioanal Chem pmid:24682147
Kaplanis M et al. Re(I) tricarbonyl complex of 1,10-phenanthroline-5,6-dione: DNA binding, cytotoxicity, anti-inflammatory and anti-coagulant effects towards platelet activating factor. 2014 J. Inorg. Biochem. pmid:24632342
Mallet de Lima CD et al. Central role of PAFR signalling in ExoU-induced NF-κB activation. 2014 Cell. Microbiol. pmid:24612488
Moschos MM et al. In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration. 2014 Cutan Ocul Toxicol pmid:24147947
Abdulnour RE et al. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25369934
Chou YI et al. Correlations of platelet-derived microparticles with thromboxane B2, platelet-activating factor, endothelin-1, and neutrophil to lymphocyte ratio in patients with coronary intermediate lesions. 2014 Biomarkers pmid:25391885
Chacón-Salinas R et al. An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation. 2014 J. Leukoc. Biol. pmid:24009177
Mehta A and Sigman M Identification and preparation of sperm for ART. 2014 Urol. Clin. North Am. pmid:24286775
Reyes-Quiroz ME et al. Platelet-activating factor downregulates the expression of liver X receptor-α and its target genes in human neutrophils. 2014 FEBS J. pmid:24289152
Semini G et al. Inositol-C2-PAF down-regulates components of the antigen presentation machinery in a 2D-model of epidermal inflammation. 2014 Biochem. Pharmacol. pmid:24291779
Sugatani J et al. Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor-deficient mice with age. 2014 FASEB J. pmid:24100020
Fang W et al. Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain. 2014 J. Neurochem. pmid:24164378
Chérifi F et al. Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor. 2014 Protein J. pmid:24384926
Rivera J et al. Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage. 2014 J. Biol. Chem. pmid:24478317
Kim KJ et al. Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation. 2014 Immunology pmid:24628121
Gazos-Lopes F et al. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi. 2014 PLoS Negl Trop Dis pmid:25101628
Semini G et al. Glycosidated phospholipids - a promising group of anti-tumour lipids. 2014 Anticancer Agents Med Chem pmid:24628240
Morimoto R et al. Rapid production of platelet-activating factor is induced by protein kinase Cα-mediated phosphorylation of lysophosphatidylcholine acyltransferase 2 protein. 2014 J. Biol. Chem. pmid:24742674
Summers C et al. Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. 2014 Thorax pmid:24706039
Yang Y et al. Basophil activation through ASGM1 stimulation triggers PAF release and anaphylaxis-like shock in mice. 2014 Eur. J. Immunol. pmid:24777913
Tarui M et al. Selective inhibitors of a PAF biosynthetic enzyme lysophosphatidylcholine acyltransferase 2. 2014 J. Lipid Res. pmid:24850807
Frazer CA Heparin-induced thrombocytopenia. 2013 Nov-Dec Medsurg Nurs pmid:24600938
Muñoz-Cano R et al. Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients. 2013 Mar-Apr Am J Rhinol Allergy pmid:23562190
Watschinger K and Werner ER Orphan enzymes in ether lipid metabolism. 2013 Biochimie pmid:22771767
Eriksson AC and Whiss PA Nanomolar concentrations of adrenaline induce platelet adhesion in vitro. 2013 Platelets pmid:22471400
Schäfer-Somi S et al. Vascular endothelial (VEGF) and epithelial growth factor (EGF) as well as platelet-activating factor (PAF) and receptors are expressed in the early pregnant canine uterus. 2013 Reprod. Domest. Anim. pmid:22458960
Yamazaki Y et al. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice. 2013 Biochem. Pharmacol. pmid:23817078
Xia SH et al. Roles of BN52021 in platelet-activating factor pathway in inflammatory MS1 cells. 2013 World J. Gastroenterol. pmid:23840141
Mazereeuw G et al. Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. 2013 Neurosci Biobehav Rev pmid:23800745
Wang C et al. Anti-platelet-activating factor, antibacterial, and antiradical activities of lipids extract from silver carp brain. 2013 Lipids Health Dis pmid:23805935
Nettis E et al. Rupatadine for the treatment of urticaria. 2013 Expert Opin Pharmacother pmid:23806068
Sato A and Ebina K [Interaction between Asp-hemolysin-related synthetic peptides and oxidized LDL/lysophospholipids]. 2013 Seikagaku pmid:23819394
Compalati E and Canonica GW Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. 2013 Curr Med Res Opin pmid:23826741
Xu H et al. Targeted lipidomics - advances in profiling lysophosphocholine and platelet-activating factor second messengers. 2013 FEBS J. pmid:23826908
Liu G et al. Characterization of streptococcal platelet-activating factor acetylhydrolase variants that are involved in innate immune evasion. 2013 Infect. Immun. pmid:23774595
Tokuoka SM et al. Alkylglycerol monooxygenase as a potential modulator for PAF synthesis in macrophages. 2013 Biochem. Biophys. Res. Commun. pmid:23743196
Stanca E et al. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: potential antiinflammatory effect of silybin. 2013 Biochim. Biophys. Acta pmid:23851051
Nagase T [Respiratory failure]. 2013 Nippon Rinsho pmid:23855209
Tao YK et al. Elevated platelet activating factor level in ischemia-related arrhythmia and its electrophysiological effect on myocardium. 2013 Biomed. Environ. Sci. pmid:23611129
Vitte J and Bongrand P Serum tryptase determination in patients with acute allergic reactions. 2013 J. Allergy Clin. Immunol. pmid:23643096
Vadas P Reply: To PMID 23040367. 2013 J. Allergy Clin. Immunol. pmid:23643097
Costa M et al. Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization. 2013 Stem Cell Res pmid:23164599
Sirangelo I et al. Amyloid toxicity and platelet-activating factor signaling. 2013 J. Cell. Physiol. pmid:23169529
Murakami M and Lambeau G Emerging roles of secreted phospholipase A(2) enzymes: an update. 2013 Biochimie pmid:23022039
Vadas P et al. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. 2013 J. Allergy Clin. Immunol. pmid:23040367
Kawano DF and Carvalho I Targeting Trypanosoma cruzi platelet-activating factor receptors: scope for the development of novel drugs to treat Chagas Disease. 2013 Mini Rev Med Chem pmid:23544467
Wei JF et al. Induction of mast-cell accumulation by promutoxin, an Arg-49 phospholipase A2. 2013 Biomed Res Int pmid:23509689
Forsman H et al. Reactivation of desensitized formyl peptide receptors by platelet activating factor: a novel receptor cross talk mechanism regulating neutrophil superoxide anion production. 2013 PLoS ONE pmid:23555913
Ruchaud-Sparagano MH et al. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis. 2013 Respirology pmid:23730995
Miyamoto-Sasaki M et al. Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. 2013 J. Atheroscler. Thromb. pmid:23739642
Nankar SA et al. Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs. 2013 Biochimie pmid:23376877
Frost BL and Caplan MS Necrotizing enterocolitis: pathophysiology, platelet-activating factor, and probiotics. 2013 Semin. Pediatr. Surg. pmid:23611612
Renteria LS et al. RhoA-Rho kinase and platelet-activating factor stimulation of ovine foetal pulmonary vascular smooth muscle cell proliferation. 2013 Cell Prolif. pmid:24033386
Verouti SN et al. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. 2013 Int J Artif Organs pmid:23335378
Zhao C et al. Important role of platelets in modulating endotoxin-induced lung inflammation in CFTR-deficient mice. 2013 PLoS ONE pmid:24367540
Barbier M et al. Lysine trimethylation of EF-Tu mimics platelet-activating factor to initiate Pseudomonas aeruginosa pneumonia. 2013 MBio pmid:23653444
Kim YH et al. PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway. 2013 J. Lipid Res. pmid:23911909
Fodran P and Minnaard AJ Catalytic synthesis of enantiopure mixed diacylglycerols – synthesis of a major M. tuberculosis phospholipid and platelet activating factor. 2013 Org. Biomol. Chem. pmid:24191360
Fontbonne H et al. Activation of bile salt dependent lipase by (lyso)phosphatidic acid and platelet activating factor. 2013 FEBS Lett. pmid:23891620
Bitencourt CS et al. Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury. 2013 J. Cell. Mol. Med. pmid:24373549